Drugs Archives - Page 42 of 66 - ��ýҕ�l Health News

Podcast: KHN’s ‘What The Health?’ The Karma Of Cutting Medicare

Stephanie Armour of The Wall Street Journal, Alice Ollstein of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss the suggested cuts to health programs in President Donald Trump’s budget proposal, the latest on lawsuits challenging work requirements for Medicaid enrollees and the FDA’s crackdown on e-cigarettes. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.

March 15, 2019

How Much Difference Will Eli Lilly’s Half-Price Insulin Make?

Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.

By Bram Sable-Smith

March 12, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

March 8, 2019

Lawmakers United Against High Drug Prices Bare Partisan Teeth

Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.

By Rachel Bluth

March 7, 2019

Cities And Counties Unlikely To Heed FDA Warning On Importing Foreign Drugs

The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.

By Phil Galewitz

March 6, 2019

The Promise Of Youth, The Reality Of Aging

Patients Experiment With Prescription Drugs To Fight Aging

Doctors and patients say they’re compelled to use off-label meds as research goes unfunded.

By Marisa Taylor

March 6, 2019

Pre$cription for Power

Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes

A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.

By Sydney Lupkin, Elizabeth Lucas, and Victoria Knight

March 4, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

March 1, 2019

Watch: Big Week For Drug Pricing Debate Featured On C-SPAN

KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.

March 1, 2019

Americans Ready To Crack Down On Drug Prices That Force Some To Skip Doses

In a new poll, consumers give thumbs up to ads that display drug prices and the removal of barriers to generics, among other cost-cutting measures.

By Jay Hancock

March 1, 2019

Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ Debate: Who’s Going To Pay

Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN’s Julie Rovner to discuss the new “Medicare-for-all” bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN’s Julie Appleby about the latest “Bill of the Month” installment.

Feb. 28, 2019

Pharma Execs Dig In For A Fight Against Outraged Senators

The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.

By Emmarie Huetteman and Jay Hancock

Feb. 26, 2019

Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices

Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.

By Emmarie Huetteman and Jay Hancock

Feb. 26, 2019

In Florida, Drug Importation From Canada Finds New Champions, Old Snags

The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.

By Shefali Luthra and Phil Galewitz

Feb. 25, 2019

Video: High Drama No Stranger At Congressional Health Care Hearings

Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.

By Julie Rovner and Mary Agnes Carey

Feb. 25, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Feb. 22, 2019

Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago

Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.

By Jay Hancock

Feb. 22, 2019

Today’s Concerns About Drug Prices Echo The Past

Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.

Feb. 22, 2019

More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids

In an emerging new tactic against the rising toll of opioid deaths, California, Ohio, Virginia and Arizona are among the states requiring physicians to offer patients naloxone when they give them prescriptions for the powerful painkillers. The Food and Drug Administration is weighing a national recommendation to do so.

By Barbara Feder Ostrov

Feb. 21, 2019